Unknown

Dataset Information

0

The rapid, massive growth of COVID-19 authors in the scientific literature.


ABSTRACT: We examined the extent to which the scientific workforce in different fields was engaged in publishing COVID-19-related papers. According to Scopus (data cut, 1 August 2021), 210 183 COVID-19-related publications included 720 801 unique authors, of which 360 005 authors had published at least five full papers in their career and 23 520 authors were at the top 2% of their scientific subfield based on a career-long composite citation indicator. The growth of COVID-19 authors was far more rapid and massive compared with cohorts of authors historically publishing on H1N1, Zika, Ebola, HIV/AIDS and tuberculosis. All 174 scientific subfields had some specialists who had published on COVID-19. In 109 of the 174 subfields of science, at least one in 10 active, influential (top 2% composite citation indicator) authors in the subfield had authored something on COVID-19. Fifty-three hyper-prolific authors had already at least 60 (and up to 227) COVID-19 publications each. Among the 300 authors with the highest composite citation indicator for their COVID-19 publications, most common countries were USA (n = 67), China (n = 52), UK (n = 32) and Italy (n = 18). The rapid and massive involvement of the scientific workforce in COVID-19-related work is unprecedented and creates opportunities and challenges. There is evidence for hyper-prolific productivity.

SUBMITTER: Ioannidis JPA 

PROVIDER: S-EPMC8422596 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8022306 | biostudies-literature
| S-EPMC8662292 | biostudies-literature
| S-EPMC7544437 | biostudies-literature
| S-EPMC8068411 | biostudies-literature
| S-EPMC7556863 | biostudies-literature
| S-EPMC8290880 | biostudies-literature
| S-EPMC7511968 | biostudies-literature
| S-EPMC3072969 | biostudies-literature
| S-EPMC3939649 | biostudies-literature
| S-EPMC8242915 | biostudies-literature